A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

King in those last days of his life was speaking to how the environment and the conditions in which people live and work ...

Bayer's booth presents regenerative agriculture products during the seventh China International Import Expo in Shanghai in November. TANG YANJUN/CHINA NEWS SERVICE Bayer Crop Science, one of the three ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.